Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

820 to 844 of 930 results

AstraZeneca buys Link Medicines neuroscience assets; enters Alzheimer's project

12-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has acquired a portfolio of neuroscience assets from…

AstraZenecaLink MedicinesMergers & AcquisitionsNeurologicalPharmaceuticalResearch

Adcock Ingram expands in Indian pharma market buying Cosme Farma brands

10-07-2012

South Africa's largest health care company Adcock Ingram (AIP: SJ) says it has reached an agreement to…

Adcock IngramCosme FarmaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Alchemia oncology demerger plans

09-07-2012

Australia-based Alchemia (ASX: ACL) says it is progressing well with preparations to demerge its oncology…

AlchemiaAudeo OncologyMergers & AcquisitionsOncologyPharmaceutical

AstraZeneca completes sale of Aptium Oncology assets

09-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says that it has completed the previously indicated sale…

Aptium OncologyAstraZenecaMergers & AcquisitionsOncologyPharmaceutical

Spectrum extends tender offer for Allos

09-07-2012

US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) said late Friday that it has again extended tender…

Allos TherapeuticsBiotechnologyFolotynMergers & AcquisitionsOncologySpectrum Pharmaceuticals

Bilthoven Biologicals acquired by Serum Institute of India

06-07-2012

Bilthoven Biologicals, a Dutch manufacturer of monoclonal antibodies and vaccines, said this week that…

Bilthoven BiologicalsBiotechnologyMergers & AcquisitionsPharmaceuticalSerum Institute of IndiaVaccines

News briefs from Merck KGaA and Sanofi

05-07-2012

German drug major Merck KGaA )MRK: DE) revealed this morning that its Phase III EXPAND trial, which assessed…

cilengitideErbituxManagementMerck KGaAMergers & AcquisitionsPharmaceuticalResearchSanofi

Blackmores acquires FIT-BioCeuticals for A$40 million

03-07-2012

Australia's Blackmores (ASX:BKL) says that it has agreed to acquire 100% of the issued share capital…

Asia-PacificBlackmoresFIT-BioCeuticalsMergers & AcquisitionsPharmaceutical

GlaxoSmithKline $2.6 billion tender offer for Human Genome Sciences saga continues

02-07-2012

Continuing its attempts to gain control of its development partner Human Genome Sciences (Nasdaq: HGSI),…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Janssen buys Germany's CorImmun

29-06-2012

US health care giant Johnson & Johnson's (NYSE: JNJ) European subsidiary Janssen-Cilag GmbH yesterday…

Cardio-vascularCorImmun GmbHJanssenJohnson & JohnsonMergers & AcquisitionsPharmaceutical

Theradiag acquires Prestizia and its MicroRNA technology platform

28-06-2012

Theradiag, (previously Biomedical Diagnostics), a Paris, France-based theranostics and in vitro diagnostics…

BiotechnologyMergers & AcquisitionsPrestiziaTheradiag

Compugen and Merck Serono set up biomarker company Neviah Genomics

25-06-2012

German drug major Merck KGaA's (MRK: DE) Merck Serono division and Israel-based Compugen (Nasdaq: CGEN)…

BiotechnologyCompugenMerck KGaAMerck SeronoMergers & AcquisitionsResearch

Merck & Co reportedly eyeing Micro Labs buy

22-06-2012

US drugs giant Merck & Co has begun talks with privately-held Indian drugmaker Micro Labs to acquire…

GenericsMerck & CoMergers & AcquisitionsMicro LabsPharmaceutical

XTL Biopharma to acquire Kitov Pharmaceuticals

21-06-2012

Israeli biopharma firm XTL Biopharmaceuticals (TASE:XTL) says it will acquire fellow Israel-based Kitov…

BiotechnologyKitov PharmaceuticalsMergers & AcquisitionsPharmaceuticalXTL Biopharmaceuticals

Walgreen to take 45% stake in Alliance Boots for $6.7 billion

20-06-2012

US drugstore chain Walgreen (NYSE: WAG) has agreed to acquire a 45% holding in pharmacy, health and beauty…

Alliance BootsMergers & AcquisitionsPharmaceuticalWalgreen

Valeant goes shopping again, this time for OraPharma

18-06-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) said Friday that it has…

FinancialMergers & AcquisitionsOraPharmaPharmaceuticalValeant Pharmaceuticals

Human Genome Sciences sets July 16 deadline for takeover bids

18-06-2012

In the latest update on UK pharma giant GlaxoSmithKline's (LSE: GSK) hostile takeover attempts for Human…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Pharming considers options, including a sale of the company

13-06-2012

Netherland-based biotech company Pharming Group (NYSE Euronext: PHARM) yesterday revealed that it is…

BiotechnologyLicensingMergers & AcquisitionsPharmingRare diseasesResearchRuconest

Lilly to increase equity position in China's Novast by $20 million

13-06-2012

US pharma major Eli Lilly (NYSE: LLY) says it will increase of its network of manufacturing capabilities…

Asia-PacificEli LillyGenericsMergers & AcquisitionsNovast LaboratoriesPharmaceutical

US regulator puts conditions on Johnson & Johnson's proposed buy of Synthes

12-06-2012

The US Federal Trade Commission will require health care giant Johnson & Johnson (NYSE: JNJ) to sell…

Johnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationSynthes

820 to 844 of 930 results

COMPANY SPOTLIGHT

Menarini

Back to top